ArticleCancer management and research2017

Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.

Runzhe Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.